Interim Immunization Protocol (RSV)
Access Resources
About
The Interim Immunization Protocol for RSV vaccines Abrysvo, Arexvy, and mResvia outlines guidelines for use. It describes the vaccine schedule, who should get vaccinated (pregnant women at 32-36 weeks and adults over 60), contraindications like severe allergies, side effects such as injection site pain and fatigue, storage instructions for each vaccine type, and reporting of adverse events. The protocol emphasizes safe administration practices to prevent injuries or allergic reactions. It also provides guidance on coadministering with other vaccines and highlights the importance of monitoring potential risks like preterm birth in pregnant women.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.